IL1B and chronic obstructive pulmonary disease: In chronic lung disease models such as chronic obstructive pulmonary disease (COPD), in vitro and ex vivo studies revealed that MTAs reduced macrophage mitochondrial ROS, improved mitophagy, and attenuated IL-1β secretion.